ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Clovis should put itself up for sale, activist Armistice says
fiercepharma
December 20, 2018Even before GlaxoSmithKline laid out an eye-popping $5.1 billion to buy PARP drugmaker Tesaro earlier this month, analysts were speculating that PARP rival Clovis Oncology would be a prime acquisition target. One of the company’s largest investors apparen
Pharma Sources Insight January 2025
